Anthropic Ships Sonnet 5 With Agentic Safety and Pricing Details
1 July 20265 min read
Illustrative image. Cedar S. Insights uses editorial stock photography; images do not depict specific events described in articles.
FDA began a first-of-its-kind pilot using cloud and AI capabilities to support real-time clinical drug trials.
A Government Executive report quoted FDA Chief AI Officer Jeremy Walsh saying the approach could reduce overall clinical trial time by 20, 30 or 40 percent.
The medicine story is operational: faster trial infrastructure could accelerate approvals, but it also raises data-quality, oversight and validation questions.
Why It Matters
Clinical trial infrastructure is becoming a major site for health AI, not just diagnosis and imaging.
What to Watch
Watch pilot outcomes, sponsor participation and FDA guidance on AI-enabled trial monitoring.
Primary Sources
Our sourcing: Cedar S. Insights provides source-led editorial analysis. Reported company, institutional and regulatory claims are attributed to their original sources unless stated otherwise.
Corrections: If a material factual error is identified, Cedar S. Insights will update the relevant article and preserve the distinction between the corrected statement and supporting evidence.
Topics
FDAClinical TrialsAI in MedicineCloud